Last Price | 9.18 | Max Price | 16.67 |
Min Price | 3.76 | 1 Year return | -10.70 |
Sector | Health Care | Subsector | Biotechnology |
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 19 | 141,925 | 0.01 % |
2020 | 476 | 170,231 | 0.28 % |
2021 | 1,146 | 252,886 | 0.45 % |
2022 | 1,982 | 238,500 | 0.83 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
Novavax to supply 40M doses of COVID-19 vaccine to South Korea
No Records Found
The core activities of Novavax Inc are in the biotech sector. The past 10 years the (international) industry gained at around 59 percent. Measured since 2011 the sector is 70 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 59 percent.
The stock lost over the past 12 months at around 84 percent. Over the past 5 years Novavax Inc' stock rose at around 9 percent in value. Novavax Inc's revenues between 2011 and 2015 were very volatile through the time and moved between 22,08 million dollars and 36,25 million dollars. Novavax Inc's net results between 2011 and 2015 were far from constant and moved between -19,36 million dollars and -156,94 million dollars.
Over the past 5 years the American company paid out dividends.
At the end of 2015 the biotech company's balance sheet was worth 386,04 million dollars. At the end of 2015 the total debt positon equaled 93,37 million dollars. This is around 24,19 percent of the total balance sheet. At the end of 2016 the American company was traded with a price/earnings-ratio of around -10. So investors paid -10 times the company's 2015's EPS. Based on it's price/earnings-ratio and dividend yield the American stock can be seen as a value stock.
The biotech company's market capitalization (the number of shares outstanding times the market value) equaled around 2,11 billion dollars. At the end of 2015 the American company had around 262,25 million stocks listed.
On this page you can find all Novavax Inc's financial reports. More information about Novavax Inc can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
36
|
15
|
31
|
34
|
19
|
476
|
Costs |
193
|
295
|
215
|
219
|
151
|
894
|
Profit |
-157
|
-280
|
-184
|
-185
|
-133
|
-418
|
Margin of profit |
-432.94
|
-1823.91
|
-589.38
|
-538.79
|
-711.09
|
-87.94
|
ROI |
-53.62
|
5044.50
|
180.64
|
110.01
|
71.33
|
-66.69
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
293
|
-6
|
-102
|
-168
|
-186
|
627
|
Debt |
93
|
400
|
404
|
376
|
359
|
955
|
Total assets |
386
|
394
|
302
|
208
|
173
|
1,582
|
Solvency |
75.81
|
-1.41
|
-33.63
|
-80.75
|
-107.55
|
39.63
|
Cash |
231
|
235
|
157
|
92
|
79
|
711
|
Cashflow |
-126
|
-259
|
-144
|
-185
|
-137
|
-43
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
-1.35
|
-0.65
|
-0.36
|
-0.49
|
-0.38
|
-0.04
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
167.80
|
25.20
|
24.80
|
36.80
|
3.98
|
Eps |
-20.68
|
-12.56
|
-9.99
|
-5.51
|
-7.27
|
Price/earnings-ratio |
-8.11
|
-2.01
|
-2.48
|
-6.68
|
-1.26
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Book value |
-0.41
|
-6.29
|
-8.74
|
-5.75
|
8.84
|
Market to book |
0.0
|
-0.25
|
-0.35
|
-0.16
|
0.96
|
Cashflow per stock |
-19.08
|
-8.94
|
-9.62
|
-4.22
|
-0.60
|
Stocks |
14
|
16
|
19
|
32
|
71
|
Market Cap |
2.275.75
|
407.27
|
476.72
|
1.190.57
|
651.35
|
Date
|
Price
|
---|---|
08 Nov 2024
|
9.18
|
05 Nov 2024
|
9.12
|
31 Oct 2024
|
9.84
|
29 Oct 2024
|
10.25
|
23 Oct 2024
|
10.12
|
19 Oct 2024
|
10.18
|
16 Oct 2024
|
12.60
|
14 Oct 2024
|
12.53
|
05 Oct 2024
|
13.61
|
02 Oct 2024
|
12.32
|
27 Sep 2024
|
12.15
|
20 Sep 2024
|
12.52
|
17 Sep 2024
|
13.20
|
13 Sep 2024
|
11.92
|
28 Aug 2024
|
11.15
|
26 Aug 2024
|
11.99
|
23 Aug 2024
|
11.96
|
11 Aug 2024
|
11.60
|
07 Aug 2024
|
11.53
|
05 Aug 2024
|
11.78
|
01 Aug 2024
|
12.81
|
30 Jul 2024
|
16.42
|
26 Jul 2024
|
16.67
|
23 Jul 2024
|
14.94
|
16 Jul 2024
|
15.12
|
10 Jul 2024
|
11.84
|
09 Jul 2024
|
12.06
|
04 Jul 2024
|
12.55
|
02 Jul 2024
|
14.00
|
26 Jun 2024
|
14.00
|